Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
Phua, Lee Cheng; Choi, Horace C W; Wu, Joseph; Jit, Mark; Low, Jeffrey; Ng, Kwong; Pearce, Fiona; Hall, Cameron; Abdul Aziz, Mohamed Ismail.
Afiliação
  • Phua LC; Agency for Care Effectiveness, Ministry of Health, Singapore.
  • Choi HCW; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Wu J; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong. Electronic addr
  • Jit M; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Low J; Gynaecologic Oncology, National University Cancer Institute, National University Hospital, Singapore.
  • Ng K; Agency for Care Effectiveness, Ministry of Health, Singapore.
  • Pearce F; Agency for Care Effectiveness, Ministry of Health, Singapore.
  • Hall C; Agency for Care Effectiveness, Ministry of Health, Singapore.
  • Abdul Aziz MI; Agency for Care Effectiveness, Ministry of Health, Singapore. Electronic address: mohamed_ismail_abdul_aziz@moh.gov.sg.
Vaccine ; 39(16): 2255-2263, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33744050

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura